GORDON CARL L
Director
Latest Insider Transactions
10 transactions (past 365 days)
| 2026-08-12 | 2026-08-10 | BLSM Blossomhill Therapeutics, Inc. | Director | Purchase | 625,000 | $16.00 | $10,000,000 |
| 2026-08-12 | 2026-08-10 | BLSM Blossomhill Therapeutics, Inc. | Director | Conversion | 1,039,996 | $0.00 | $0 |
| 2026-08-12 | 2026-08-10 | BLSM Blossomhill Therapeutics, Inc. | Director | Conversion | 1,049,283 | $0.00 | $0 |
| 2026-08-10 | 2026-08-06 | BLSM Blossomhill Therapeutics, Inc. | Director | Award | 23,904 | $16.00 | $382,464 |
| 2026-07-29 | 2026-07-27 | SCTX Scribe Therapeutics, Inc. | Director | Conversion | 348,825 | $0.00 | $0 |
| 2026-07-29 | 2026-07-27 | SCTX Scribe Therapeutics, Inc. | Director | Purchase | 1,000,000 | $15.00 | $15,000,000 |
| 2026-07-28 | 2026-07-23 | SCTX Scribe Therapeutics, Inc. | Director | Award | 14,725 | $15.00 | $220,875 |
| 2026-01-05 | 2026-01-02 | CMPX Compass Therapeutics, Inc. | Director | Award | 90,000 | $0.00 | $0 |
| 2025-12-18 | 2025-11-21 | KROS Keros Therapeutics, Inc. | Director | Disposition | 74,465 | $17.75 | -$1,321,754 |
| 2025-12-18 | 2025-11-21 | KROS Keros Therapeutics, Inc. | Director | Disposition | 140,057 | $17.75 | -$2,486,012 |
BLSM
Director
Purchase
$10M
625,000 shares @ $16.00
Filed 2026-08-12Trade 2026-08-10
Blossomhill Therapeutics, Inc.BLSM
Director
Conversion
$0
1,039,996 shares @ $0.00
Filed 2026-08-12Trade 2026-08-10
Blossomhill Therapeutics, Inc.BLSM
Director
Conversion
$0
1,049,283 shares @ $0.00
Filed 2026-08-12Trade 2026-08-10
Blossomhill Therapeutics, Inc.BLSM
Director
Award
$382.5K
23,904 shares @ $16.00
Filed 2026-08-10Trade 2026-08-06
Blossomhill Therapeutics, Inc.SCTX
Director
Conversion
$0
348,825 shares @ $0.00
Filed 2026-07-29Trade 2026-07-27
Scribe Therapeutics, Inc.SCTX
Director
Purchase
$15M
1,000,000 shares @ $15.00
Filed 2026-07-29Trade 2026-07-27
Scribe Therapeutics, Inc.SCTX
Director
Award
$220.9K
14,725 shares @ $15.00
Filed 2026-07-28Trade 2026-07-23
Scribe Therapeutics, Inc.KROS
Director
Disposition
-$1.3M
74,465 shares @ $17.75
Filed 2025-12-18Trade 2025-11-21
Keros Therapeutics, Inc.KROS
Director
Disposition
-$2.5M
140,057 shares @ $17.75
Filed 2025-12-18Trade 2025-11-21
Keros Therapeutics, Inc.